Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection

Journal of Clinical Investigation

Volumn 125, Issue 2, 2015, Pages 752-768

  Tzelepis, Fanny ^a   Verway, Mark ^a   Daoud, Jamal ^b   Gillard, Joshua ^a   Hassani Ardakani, Kimya ^a   Dunn, Jonathan ^a   Downey, Jeffrey ^a   Gentile, Marilena Elena ^a   Jaworska, Joanna ^a   Sanchez, Anthony Michel Jean ^a,e   Nédélec, Yohann ^c   Vali, Hojatollah ^d   Tabrizian, Maryam ^b   Kristof, Arnold Scott ^a   King, Irah Luther ^a   Barreiro, Luis Bruno ^c   Divangahi, Maziar ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITÉ DE PERPIGNAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; DOWN REGULATION; EFFEROCYTOSIS; HUMAN; HUMAN CELL; IMMUNE EVASION; INFECTION SENSITIVITY; LUNG TUBERCULOSIS; MONOCYTE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY; PHAGOCYTOSIS; TUBERCULOSIS;

ANIMALS; ANNEXIN A1; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; MICE; MICE, KNOCKOUT; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; TUBERCULOSIS;

EID: 84961287867     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI77014     Document Type: Article

References (70)

1. Chen CY, et al. A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathog. 2009;5(4):e1000392.
2. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A. 1992;89(24):12013-12017.
3. + T cells and their role in immunity. Crit Rev Immunol. 2006;26(4):317-352.
4. + cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol. 1999;162(1):372-379.
5. Grotzke JE, Siler AC, Lewinsohn DA, Lewinsohn DM. Secreted immunodominant Mycobacterium tuberculosis antigens are processed by the cytosolic pathway. J Immunol. 2010;185(7):4336-4343.
6. Mantegazza AR, Magalhaes JG, Amigorena S, Marks MS. Presentation of phagocytosed antigens by MHC class I and II. Traffic Cph Den. 2013;14(2):135-152.
7. Albert ML. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol. 2004;4(3):223-231.
8. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392(6671):86-89.
9. Bosnjak L, Miranda-Saksena M, Koelle DM, Boadle RA, Jones CA, Cunningham AL. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows crosspresentation via uninfected dendritic cells. J Immunol. 2005;174(4):2220-2227.
10. Yrlid U, Wick MJ. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J Exp Med. 2000;191(4):613-624.
11. Schaible UE, et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med. 2003;9(8):1039-1046.
12. Winau F, et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity. 2006;24(1):105-117.
13. Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol. 2010;8(9):668-674.
14. Behar SM, Martin CJ, Nunes-Alves C, Divangahi M, Remold HG. Lipids, apoptosis, and crosspresentation: links in the chain of host defense against Mycobacterium tuberculosis. Microbes Infect Inst Pasteur. 2011;13(8-9):749-756.
15. Divangahi M, et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol. 2009;10(8):899-906.
16. Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat Immunol. 2010;11(8):751-758.
17. Martin CJ, et al. Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe. 2012;12(3):289-300.
18. Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 2006;129(6):1673-1682.
19. Li W. Eat-me signals: keys to molecular phagocyte biology and "appetite" control. J Cell Physiol. 2012;227(4):1291-1297.
20. Paidassi H, Tacnet-Delorme P, Arlaud GJ, Frachet P. How phagocytes track down and respond to apoptotic cells. Crit Rev Immunol. 2009;29(2):111-130.
21. Albert ML, et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 1998;188(7):1359-1368.
22. Nakayama M, et al. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009;113(16):3821-3830.
23. + murine dendritic cells. J Immunol. 2002;168(12):6057-6065.
24. Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol. 1995;76(2):195-202.
25. Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 2009;9(1):62-70.
26. Perretti M, Dalli J. Exploiting the Annexin A1 pathway for the development of novel antiinflammatory therapeutics. Br J Pharmacol. 2009;158(4):936-946.
27. Arur S, et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell. 2003;4(4):587-598.
28. D'Acquisto F, et al. Annexin-1 modulates T-cell activation and differentiation. Blood. 2007;109(3):1095-1102.
29. D'Acquisto F, Paschalidis N, Sampaio ALF, Merghani A, Flower RJ, Perretti M. Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. Eur J Immunol. 2007;37(11):3131-3142.
30. D'Acquisto F, Piras G, Rattazzi L. Pro-inflammatory and pathogenic properties of Annexin-A1: the whole is greater than the sum of its parts. Biochem Pharmacol. 2013;85(9):1213-1218.
31. Gan H, Lee J, Ren F, Chen M, Kornfeld H, Remold HG. Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol. 2008;9(10):1189-1197.
32. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-β, yet succumb to tuberculosis. J Immunol. 1999;162(9):5407-5416.
33. Winau F, Kaufmann SHE, Schaible UE. Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria. Cell Microbiol. 2004;6(7):599-607.
34. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med. 2002;195(10):1289-1302.
35. Viaud S, et al. Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res. 2010;70(4):1281-1285.
36. Huggins A, Paschalidis N, Flower RJ, Perretti M, D'Acquisto F. Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation. FASEB J. 2009;23(4):985-996.
37. Hannon R, et al. Aberrant inflammation and resistance to glucocorticoids in annexin 1-/-mouse. FASEB J. 2003;17(2):253-255.
38. Chen M, et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med. 2008;205(12):2791-2801.
39. + dendritic cells in cytotoxic T cell immunity. Science. 2008;322(5904):1097-1100.
40. Barreiro LB, Tailleux L, Pai AA, Gicquel B, Marioni JC, Gilad Y. Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A. 2012;109(4):1204-1209.
41. Pilli M, et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012;37(2):223-234.
42. Blackwell GJ, Carnuccio R, Di Rosa M, Flower RJ, Parente L, Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980;287(5778):147-149.
43. Flower RJ. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol. 1988;94(4):987-1015.
44. Parente L, Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm Res. 2004;53(4):125-132.
45. Da Cunha EE, Oliani SM, Damazo AS. Effect of annexin-A1 peptide treatment during lung inflammation induced by lipopolysaccharide. Pulm Pharmacol Ther. 2012;25(4):303-311.
46. Getting SJ, Flower RJ, Perretti M. Inhibition of neutrophil and monocyte recruitment by endogenous and exogenous lipocortin 1. Br J Pharmacol. 1997;120(6):1075-1082.
47. Poon IKH, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014;14(3):166-180.
48. + T cell immunity. PLoS One. 2013;8(4):e62449.
49. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol. 2009;9(5):353-363.
50. + pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J Exp Med. 2011;208(9):1789-1797.
51. + dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci U S A. 2006;103(28):10729-10734.
52. + conventional dendritic cells. J Exp Med. 2010;207(4):823-836.
53. Gene Skyline. annexin A1 probe 10466606. Immunological Genome Project Web site. http://www.immgen.org/databrowser/index.html. Accessed November 19, 2014.
54. Kang J-H, Li M, Chen X, Yin X-M. Proteomics analysis of starved cells revealed Annexin A1 as an important regulator of autophagic degradation. Biochem Biophys Res Commun. 2011;407(3):581-586.
55. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119(6):753-766.
56. Ponpuak M, et al. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity. 2010;32(3):329-341.
57. Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL Jr, Eissa NT. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med. 2009;15(3):267-276.
58. Patterson NL, Mintern JD. Intersection of autophagy with pathways of antigen presentation. Protein Cell. 2012;3(12):911-920.
59. Li Y, Wang L-X, Yang G, Hao F, Urba WJ, Hu H-M. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res. 2008;68(17):6889-6895.
60. Li W, et al. Autophagy genes function sequentially to promote apoptotic cell corpse degradation in the engulfing cell. J Cell Biol. 2012;197(1):27-35.
61. Diakonova M, Gerke V, Ernst J, Liautard JP, Van Der Vusse G, Griffiths G. Localization of five annexins in J774 macrophages and on isolated phagosomes. J Cell Sci. 1997;110(pt 10):1199-1213.
62. 2+ and requires an intact N-terminal domain. Mol Biol Cell. 1996;7(9):1359-1374.
63. Bitto E, Li M, Tikhonov AM, Schlossman ML, Cho W. Mechanism of annexin I-mediated membrane aggregation. Biochemistry. 2000;39(44):13469-13477.
64. De La Fuente M, Parra AV. Vesicle aggregation by annexin I: role of a secondary membrane binding site. Biochemistry. 1995;34(33):10393-10399.
65. Hu NJ, Bradshaw J, Lauter H, Buckingham J, Solito E, Hofmann A. Membrane-induced folding and structure of membrane-bound annexin A1 N-terminal peptides: implications for annexininduced membrane aggregation. Biophys J. 2008;94(5):1773-1781.
66. World Health Organization. Global Tuberculosis Report 2013. Geneva, Switzerland: World Health Organization; 2013.
67. + T cell memory. J Immunol. 2013;190(3):1066-1075.
68. Qiu CH, Miyake Y, Kaise H, Kitamura H, Ohara O, Tanaka M. Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol. 2009;182(7):4127-4136.
69. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3: Article3.
70. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100(16):9440-9445.